Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Marchesini, Matteo
155  Ergebnisse:
Personensuche X
?
1

Targeting DNA2 overcomes metabolic reprogramming in multipl..:

Thongon, Natthakan ; Ma, Feiyang ; Baran, Natalia...
Nature Communications.  15 (2024)  1 - p. , 2024
Link: https://doi.org/10.1038/..
 
?
2

P-056 Role the combination of FDG pet plus whole body MRI f..:

Cerchione, Claudio ; Nappi, Davide ; Marchesini, Matteo...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S65-S66 , 2023
Link: https://doi.org/10.1016/..
 
?
3

P953: ROLE OF THE COMBINATION OF FDG PET PLUS WHOLE BODY MR..:

Cerchione, Claudio ; Nappi, Davide ; Marchesini, Matteo...
HemaSphere.  7 (2023)  S3 - p. e3315114 , 2023
Link: https://doi.org/10.1097/..
 
?
4

P918: ROLE OF THE COMBINATION OF FDG PET PLUS WHOLE BODY MR..:

Cerchione, Claudio ; Nappi, Davide ; Marchesini, Matteo...
HemaSphere.  7 (2023)  S3 - p. e19651f8 , 2023
Link: https://doi.org/10.1097/..
 
?
5

MM-602 Role of the Combination of FDG-PET Plus Whole Body M..:

Cerchione, Claudio ; Nappi, Davide ; Marchesini, Matteo...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S510 , 2023
Link: https://doi.org/10.1016/..
 
?
6

POSTER: MM-638 Role of the Combination of FDG-PET plus Whol..:

Cerchione, Claudio ; Nappi, Davide ; Marchesini, Matteo...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S223 , 2023
Link: https://doi.org/10.1016/..
 
?
7

P-057 Role of the combination of FDG-PET plus whole body MR..:

Cerchione, Claudio ; Nappi, Davide ; Marchesini, Matteo...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S66 , 2023
Link: https://doi.org/10.1016/..
 
?
8

P451: GENE FUSIONS AND OTHER GENOMIC EVENTS UNDERLIE VENETO..:

Ferrari, Anna ; Zacheo, Irene ; Fonzi, Eugenio...
HemaSphere.  7 (2023)  S3 - p. e25315b3 , 2023
Link: https://doi.org/10.1097/..
 
?
9

P-206 3D in vitro modelling of relapsed/refractory multiple..:

Oriani, Matilde ; Alassi, Nour ; Spadazzi, Chiara...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S148-S149 , 2023
Link: https://doi.org/10.1016/..
 
?
10

POSTER: MM-602 Role of the Combination of FDG-PET Plus Whol..:

Cerchione, Claudio ; Nappi, Davide ; Marchesini, Matteo...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S222 , 2023
Link: https://doi.org/10.1016/..
 
?
11

MM-638 Role of the Combination of FDG-PET plus Whole Body M..:

Cerchione, Claudio ; Nappi, Davide ; Marchesini, Matteo...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S513 , 2023
Link: https://doi.org/10.1016/..
 
?
12

Poster: MM-498 Addition of Carfilzomib as a Third Agent in ..:

Cerchione, Claudio ; Catalano, Lucio ; Nappi, Davide...
Clinical Lymphoma Myeloma and Leukemia.  22 (2022)  - p. S183 , 2022
Link: https://doi.org/10.1016/..
 
?
13

MM-498 Addition of Carfilzomib as a Third Agent in Lenalido..:

Cerchione, Claudio ; Catalano, Lucio ; Nappi, Davide...
Clinical Lymphoma Myeloma and Leukemia.  22 (2022)  - p. S426-S427 , 2022
Link: https://doi.org/10.1016/..
 
?
14

P-184: Pegfilgrastim versus filgrastim in the supportive ca..:

Cerchione, Claudio ; Catalano, lucio ; Nappi, Davide...
Clinical Lymphoma Myeloma and Leukemia.  22 (2022)  - p. S136 , 2022
Link: https://doi.org/10.1016/..
 
?
15

P-185: Domestic opportunity in heavily pretreated multiple ..:

Cerchione, Claudio ; Nappi, Davide ; Catalano, lucio...
Clinical Lymphoma Myeloma and Leukemia.  22 (2022)  - p. S136-S137 , 2022
Link: https://doi.org/10.1016/..
 
1-15